Siga Technologies SIGA
NASDAQ SIGA
$3.09 -0.11 (-3.44%)
As of: Sep 9, 2026 · 3:59 PM EDT

Siga Technologies (SIGA) Cost of Revenue (2018 - 2025)

Siga Technologies' (SIGA) quarterly Cost of Revenue came in at $1.0 million in Q3 2025, down 38.16% on a YoY basis from $1.6 million in Q3 2024, and down 96.08% quarter-over-quarter from $25.6 million in Q2 2025.

Analysis

Siga Technologies (SIGA) Cost of Revenue (2018 - 2025) Analysis & Trends

Siga Technologies (SIGA) has reported Cost of Revenue for 8 consecutive years, with $1.0 million the latest figure, recorded in Q3 2025.

  • For the quarter ending Q3 2025, Cost of Revenue fell 38.16% year-over-year to $1.0 million; the trailing twelve-month figure through Sep 2025 stood at $40.8 million (up 27.8% YoY), and the FY2024 full-year result was $31.3 million, up 75.53% from the prior year.
  • Cost of Revenue fell to $1.0 million in Q3 2025 per SIGA's latest filing, from $25.6 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $25.6 million in Q2 2025 and bottomed at $83276.0 in Q3 2021.
  • Historically, Cost of Revenue has averaged $5.4 million across 5 years, with a median of $1.2 million in 2023.
  • The sharpest annual moves came in 2021 and 2022: Cost of Revenue tumbled 98.5% in 2021, then soared 4642.03% in 2022.
  • Over 5 years, Cost of Revenue stood at $15.3 million in 2021, then tumbled by 94.23% to $881375.0 in 2022, then surged by 1579.64% to $14.8 million in 2023, then retreated by 4.54% to $14.1 million in 2024, then slumped by 92.91% to $1.0 million in 2025.
  • According to Business Quant data, Cost of Revenue over the past three periods registered $1.0 million, $25.6 million, and $157738.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn 8.05 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn 4.29 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn 4.40 Bn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn 3.71 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn 4.09 Bn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn 3.51 Bn
7 Revolution Medicines 43.79 Bn 43.79 Bn - -
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn 104.96 Mn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn 99.50 Mn
10 Siga Technologies 220.19 Mn 65.22 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 1.00 Mn
Jun 30, 2025 25.55 Mn
Mar 31, 2025 157,738.00
Dec 31, 2024 14.13 Mn
Sep 30, 2024 1.62 Mn
Jun 30, 2024 12.31 Mn
Mar 31, 2024 3.23 Mn
Dec 31, 2023 14.80 Mn
Sep 30, 2023 896,537.00
Jun 30, 2023 974,420.00
Mar 31, 2023 1.15 Mn
Dec 31, 2022 881,375.00
Sep 30, 2022 3.95 Mn
Jun 30, 2022 882,096.00
Mar 31, 2022 4.72 Mn
Dec 31, 2021 15.27 Mn
Sep 30, 2021 83,276.00
Jun 30, 2021 995,990.00
Mar 31, 2021 250,848.00
Dec 31, 2020 4.33 Mn